What You Will Learn
Traditional stock screeners give you a filtered list and stop there. You get fifty tickers matching your P/E and market cap criteria, but you still have to research every one individually to separate genuine quality from value traps. Journely does the deep analysis as part of the screening — pulling 5 years of financials, scoring quality across multiple dimensions, and explicitly telling you which stocks to avoid and why.
This tutorial shows a real screening run from February 15, 2026. The prompt was simple: "Screen for quality growth stocks in Japan with strong fundamentals." Journely analyzed 7 candidates across revenue growth, profitability, balance sheet strength, and competitive positioning — producing quality scores from 95/100 (strong buy) down to 20/100 (avoid). Every finding below is actual output.
- Deep quality analysis — 5-year revenue trajectories, margin trends, ROE/ROIC, balance sheet health, and FCF conversion for every candidate
- Quality scoring — each stock receives a composite score (0-100) that weighs growth consistency, profitability, leverage, and valuation
- Value trap detection — cheap P/E ratios exposed as traps when backed by negative FCF, excessive leverage, or collapsing profitability
- Clear recommendations — not just a filtered list, but explicit buy, hold, and avoid calls with reasoning
Screening Japan for Quality Growth
Ask in Plain Language
No filters to configure. No industry codes to select. Describe what you want and Journely interprets your intent. It identifies the market (Japan), the style (growth), the quality bar (strong fundamentals), and builds the appropriate analysis.
Screening Japanese equities for quality growth characteristics: consistent revenue growth, expanding profitability, strong balance sheet, and competitive moats. Analyzing 7 candidates across all fundamental dimensions with 5 years of financial data.
The Top Picks — With Real Numbers
Journely does not just filter and rank. It provides detailed company analysis with 5-year financial trends, profitability metrics, balance sheet assessment, competitive moat evaluation, and a quality score. Here are the two stocks that scored highest.
Revenue: ¥755B (2022) → ¥922B (2023) → ¥967B (2024) → ¥1,059B (2025): +9.5% YoY growth, consistent. Net Income: ¥303B → ¥363B → ¥370B → ¥399B: +7.8% YoY. EPS accelerating at +13% YoY.
Profitability: Gross margin 83% (best-in-class), operating margin 51%, net margin 37%. ROE 13.2%, ROIC 13.2%.
Balance sheet: Zero debt. ¥3.1T equity. ¥579B cash. ¥1.46T working capital. Fortress.
Moat: Industrial automation sensors, vision systems, and measurement equipment. High switching costs and deep technical expertise. P/E 32.25x is premium but justified by 83% margins and consistent growth.
Verdict: STRONG BUY.
EPS growth: +31.5% YoY (accelerating). Revenue: ¥3,557B, +4.1% growth. Net income ¥409B, +15.6% YoY.
Profitability: ROE 27.5% (excellent), ROIC 25.2% (exceptional capital efficiency). Gross margin 57.7%, net margin 12.8%.
Balance sheet: Debt/equity only 12.9%. ¥809B cash. FCF ¥545B (very healthy).
Moat: HR technology platform (Indeed, recruiting marketplace). Network effects in job matching. P/E 19.22x is reasonable given 27.5% ROE and accelerating earnings.
Verdict: BUY — best risk/reward among Japan growth stocks.
Not just a ranking — a quality framework
The quality score combines multiple dimensions: growth consistency (are revenues steadily rising or volatile?), profitability level (margins relative to peers), balance sheet health (leverage and cash coverage), and capital efficiency (ROE and ROIC). A stock scoring 95/100 like Keyence excels across all dimensions. A stock scoring 25/100 like SoftBank may have one attractive metric (cheap P/E) but fails on the others.
Value Traps Identified and Avoided
This is where Journely's screening goes beyond any filter-based tool. Three of the seven candidates were flagged as explicit avoids — not because they did not match the search criteria, but because deeper analysis revealed fundamental quality problems that a simple P/E filter would miss.
P/E of 6.85x appears cheap — but it is a trap. Debt/equity is 163% (extremely high). Free cash flow is negative at -¥650B. Net income swings from -¥1.7T losses to +¥1.15T gains because earnings are driven by Vision Fund investment valuations, not core business performance. ROE of 26.7% is artificially boosted by leverage, not operational excellence.
A failing turnaround story. Net margin collapsed from +22.8% (2023) to -3.9% (2025). ROE is -2.1%. ROIC is -1.4%. Revenue is declining despite the broader semiconductor industry recovery. This is not a quality growth play — profitability is being destroyed.
Cash-rich balance sheet (¥1.6T in cash, near-zero debt) masks a declining business. Revenue fell 30% to ¥1,165B. Net income dropped 43%. The Switch console cycle is ending and FCF turned negative. Despite iconic franchises (Mario, Zelda, Pokemon), this is not a growth stock at 24x P/E with shrinking earnings.
Why "avoid" calls matter
Most screening tools only tell you what to buy. Journely tells you what NOT to buy and why — which is often more valuable. SoftBank at 6.85x P/E looks like a bargain on any standard screener. But the 163% debt/equity and negative ¥650B free cash flow make it a capital destruction machine. Without the deep analysis, a filter-based screener would rank it as the cheapest stock in Japan.
The Complete Quality Ranking
After analyzing all seven candidates, Journely produces a final ranked table with quality scores, key metrics, and clear recommendations. This is the output that took under two minutes to generate — replacing what would take hours of manual research across financial databases and annual reports.
1. Keyence (95/100) — 83% gross margin, 37% net margin, 9.5% growth, zero debt. STRONG BUY.
2. Recruit Holdings (88/100) — 27.5% ROE, +31.5% EPS growth, 13% debt/equity. BUY.
3. Tokyo Electron (78/100) — 25.9% ROIC, 21% net margin, but P/E 38x and cyclical semiconductor equipment. HOLD/BUY.
4. Sony (65/100) — Diversified and stable, but ¥1T impairment charge and conglomerate complexity. HOLD.
5. Nintendo (55/100) — Cash-rich but revenue -30%, earnings -43%. AVOID.
6. SoftBank (25/100) — Value trap. 163% debt/equity, -¥650B FCF. AVOID.
7. Renesas (20/100) — Profitability collapsing, negative ROE/ROIC. AVOID.
What Makes This Different
- Screening includes deep analysis — not a filtered list of tickers, but 5-year financial analysis with quality scores for every candidate. Revenue trajectories, margin trends, balance sheet health, and competitive moat evaluation included
- Value traps caught — SoftBank at 6.85x P/E would top any "cheap Japan stocks" screener. Journely flagged it as a trap: 163% debt/equity, negative ¥650B FCF, and earnings driven by investment portfolio swings. Renesas flagged as failing turnaround with collapsing profitability
- Explicit avoid calls — 3 of 7 candidates were rated "avoid" with specific reasoning. Most tools only show you what passed the filter; Journely shows what failed and why
- Cross-market capability — this screen ran on Japanese equities with yen-denominated financials. The same prompt works for US, Vietnamese, or cross-market screening
- Every number is real — Keyence's 83% gross margin, Recruit's 27.5% ROE, SoftBank's -¥650B FCF. Actual financial data from February 2026, not hypothetical examples